New radiation approach targets inoperable kidney tumors
NCT ID NCT04473781
First seen Mar 10, 2026 · Last updated May 07, 2026 · Updated 8 times
Summary
This early-phase study tests a type of internal radiation called brachytherapy for people with large kidney cancers (4-10 cm) that cannot be surgically removed or treated with standard ablation. The treatment places a temporary radiation source directly into the tumor to kill cancer cells and slow growth. The study aims to find the safest dose and see if it can keep the tumor from growing or spreading. About 17 participants who have refused or are not candidates for surgery will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE I RENAL CELL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90095, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.